NCT02447627View on ClinicalTrials.gov

Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell Disease

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
HealthySickle Cell Disease
Trial Locations (1)

48201

Research Site, Detroit

Sponsors
All Listed Sponsors
lead

Bioverativ Therapeutics Inc.

INDUSTRY

NCT02447627 - Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell Disease | Biotech Hunter | Biotech Hunter